← My Government dashboard

Government Watch

Dossier Legislative introduced 17-jul-2025
Bill introduced in Congress — not yet passed by either chamber, and not law.

Right to FDA-Approved Medicines Act

Key claim: The Right to FDA-Approved Medicines Act (HR4525, 119th Congress) was introduced and referred to the House Committee on Energy and Commerce on July 17, 2025.

Abstract

(HR4525 · 119th Congress) Latest action (2025-07-17): Referred to the House Committee on Energy and Commerce.

Why this matters

The bill signals continued congressional interest in patient access to FDA-approved medicines, a recurring theme in coverage and formulary debates affecting what patients can obtain and what payers must cover. Until committee action or text analysis clarifies scope, the practical implications for patients, providers, and insurers remain undetermined.

Source

Link

Briefing card

Right to FDA-Approved Medicines Act
Stage: introduced · congress · 17-jul-2025

The Right to FDA-Approved Medicines Act (HR4525, 119th Congress) was introduced and referred to the House Committee on Energy and Commerce on July 17, 2025.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: congress:119-hr-4525:introduced

Ask about this finding

Replies are grounded in the abstract and metadata above. The model will quote directly when possible and say so if a question isn't covered.

Stages other doctrine resolution introduced proposed rule passed chamber executive action final rule enacted district opinion circuit opinion opinion

build build 392 · ea9c128-dirty · 2026-08-09